ArticleJournal of the Canadian Association of Gastroenterology2026

An observational cohort study evaluating adalimumab concentrations for predicting non-recapture of biochemical response after dose escalation in patients with Crohn's disease experiencing secondary loss of response.

Davide De Marco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.